DekaBank Deutsche Girozentrale’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $208K | Hold |
89,700
| – | – | ﹤0.01% | 1119 |
|
2025
Q1 | $639K | Hold |
89,700
| – | – | ﹤0.01% | 921 |
|
2024
Q4 | $1.01M | Hold |
89,700
| – | – | ﹤0.01% | 873 |
|
2024
Q3 | $1.61M | Hold |
89,700
| – | – | ﹤0.01% | 798 |
|
2024
Q2 | $1.92M | Hold |
89,700
| – | – | ﹤0.01% | 773 |
|
2024
Q1 | $2.42M | Hold |
89,700
| – | – | ﹤0.01% | 721 |
|
2023
Q4 | $2.77M | Hold |
89,700
| – | – | 0.01% | 708 |
|
2023
Q3 | $1.85M | Hold |
89,700
| – | – | ﹤0.01% | 757 |
|
2023
Q2 | $1.8M | Hold |
89,700
| – | – | ﹤0.01% | 772 |
|
2023
Q1 | $1.44M | Hold |
89,700
| – | – | ﹤0.01% | 794 |
|
2022
Q4 | $1.72M | Hold |
89,700
| – | – | ﹤0.01% | 757 |
|
2022
Q3 | $1.24M | Sell |
89,700
-60,500
| -40% | -$834K | ﹤0.01% | 819 |
|
2022
Q2 | $1.92M | Hold |
150,200
| – | – | 0.01% | 739 |
|
2022
Q1 | $2.4M | Buy |
150,200
+18,700
| +14% | +$298K | 0.01% | 712 |
|
2021
Q4 | $2.94M | Buy |
131,500
+2,200
| +2% | +$49.2K | 0.01% | 689 |
|
2021
Q3 | $3.84M | Hold |
129,300
| – | – | 0.01% | 592 |
|
2021
Q2 | $5.52M | Buy |
129,300
+75,000
| +138% | +$3.2M | 0.02% | 501 |
|
2021
Q1 | $2.32M | Buy |
54,300
+7,000
| +15% | +$299K | 0.01% | 659 |
|
2020
Q4 | $2.61M | Sell |
47,300
-26,400
| -36% | -$1.46M | 0.01% | 606 |
|
2020
Q3 | $1.68M | Buy |
+73,700
| New | +$1.68M | 0.01% | 626 |
|
2016
Q2 | – | Sell |
-2,875
| Closed | -$85K | – | 1032 |
|
2016
Q1 | $85K | Buy |
+2,875
| New | +$85K | ﹤0.01% | 983 |
|